Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01019057 · ClinicalTrials.gov registry record

An Evaluation of Interlaminar Lumbar Instrumented (ILIF™)

A clinical trial of Degenerative Disc Disease, sponsored by NuVasive.

Completed
Registry status
77
Enrollment target
8
Study locations

NCT01019057 is a study of Degenerative Disc Disease that has completed, run by NuVasive. The registered enrollment target is 77 participants, below the 167-participant average among 42 other Degenerative Disc Disease trials with a reported enrollment target (54% lower). The trial reports 8 study locations across 7 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01019057, a study of Degenerative Disc Disease, has completed, sponsored by NuVasive.

COMPLETED
Registry status
77 participants
Enrollment target
8
Study locations

Study Summary

Patients diagnosed with single-level degenerative disc disease (DDD) of the lumbar spine undergo a posterior decompression followed by a fusion complete with a spinous process plate, graft, and a biologic.

Conditions Studied

Interventions

  • PROCEDURE ILIF

Study Locations (8)

South Carolina

  • Coastal Orthopaedic Associates PA - Conway
  • McLeod Regional Medical Center - Florence

Arizona

  • Desert Institute for Spine Care, Surgical Specialty Hospital of Arizona - Phoenix

California

  • The Spine Institute, St. John's Health Center - Santa Monica

Florida

  • North Florida Regional Medical Center - Gainesville

New Mexico

  • Lovelace Medical Center - Albuquerque

Texas

  • Center for Neurological Disorders, Texas Health Harris Methodist Fort Worth - Fort Worth

Virginia

  • Neurosurgical Specialists, DePaul Medical Center - Norfolk

Trial Details

FieldValue
Enrollment Target 77 participants
Start Date 2009-11
Est. Completion 2014-06

Sponsor

NuVasive

28 total trials

What the Registry Record Tells You About NCT01019057

The ClinicalTrials.gov registry entry for NCT01019057 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 77 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 167-participant average among 42 other Degenerative Disc Disease trials with a reported enrollment target (54% lower). The listed sponsor is NuVasive, which has 28 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Degenerative Disc Disease appearing as the primary indexed condition, and to 1 intervention - of which ILIF is the first listed.

NCT01019057 reports 8 study locations spanning 7 distinct geographic areas - top geographies include South Carolina, Arizona, California.

Frequently Asked Questions

What is clinical trial NCT01019057 about?

NCT01019057 is a clinical study titled "An Evaluation of Interlaminar Lumbar Instrumented (ILIF™)". Patients diagnosed with single-level degenerative disc disease (DDD) of the lumbar spine undergo a posterior decompression followed by a fusion complete with a spinous process plate, graft, and a biologic.

What is the current status of trial NCT01019057?

This trial is currently completed. The enrollment target is 77 participants. The study started on 2009-11. Estimated completion is 2014-06.

What conditions does trial NCT01019057 study?

This clinical trial studies the following conditions: Degenerative Disc Disease.

What interventions are being tested in trial NCT01019057?

The interventions under investigation include: ILIF (PROCEDURE).

Who is sponsoring clinical trial NCT01019057?

This trial is sponsored by NuVasive, which has 28 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01019057 being conducted?

This trial has 8 study locations across Arizona, California, Florida, New Mexico, South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Degenerative Disc Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.